Determinants of post discharge mortality among hospitalized COVID-19 patients

被引:3
|
作者
Kumar, Gunjan [1 ]
Talukdar, Arunansu [2 ]
Turuk, Alka [1 ]
Bhalla, Ashish [4 ]
Mukherjee, Subhasis [3 ]
Bhardwaj, Pankaj [5 ]
Bhatnagar, Tarun [6 ]
Mukherjee, Aparna [1 ]
机构
[1] Indian Council Med Res, Clin Studies & Trials Unit, New Delhi 110029, India
[2] Med Coll & Hosp, Dept Geriatr Med, Kolkata, W Bengal, India
[3] Coll Med & Sagore Dutta Hosp, Dept Resp Med, Kolkata, W Bengal, India
[4] Inst Med Educ & Res, Dept Internal Med, Chandigarh, India
[5] All India Inst Med Sci, Sch Publ Hlth, Dept Community Med & Family Med, Jodhpur, Rajasthan, India
[6] ICMR Natl Inst Epidemiol, Sch Publ Hlth, Chennai, Tamil Nadu, India
关键词
India; observational study; one-year mortality; persistent symptoms; post-acute COVID symptoms;
D O I
10.4103/ijmr.ijmr_973_23
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background & objectives: The post-acute effects of COVID-19 are continually being updated. This investigation was conducted to evaluate the determinants of post discharge mortality in hospitalized COVID-19 patients, especially 18-45 yr of age. Methods: A series of three nested case-control analyses was conducted on follow up data collected in the National Clinical Registry for COVID-19 between September 2020 and February 2023 from 31 hospitals. Matching (1:4) was done by the date of hospital admission +/- 14 days for the following comparisons: (i) casepatients reported as dead vs. controls alive at any contact within one year follow up; (ii) the same in the 18-45 yr age group and (iii) case-patients reported as dead between the first and one year of follow up vs. controls alive at one year post discharge. Results: The one year post discharge mortality was 6.5 per cent (n=942). Age [<= 18 yr: adjusted odds ratio (aOR) (95% confidence interval [CI]): 1.7 (1.04, 2.9); 40-59 yr: aOR (95% CI): 2.6 (1.9, 3.6); >= 60 yr: aOR (95% CI): 4.2 ( 3.1, 5.7)], male gender [aOR (95% CI): 1.3 ( 1.1, 1.5)], moderate-tosevere COVID-19 [aOR (95% CI): 1.4 (1.2, 1.8)] and comorbidities [aOR (95%CI): 1.8 (1.4, 2.2)] were associated with higher odds of post-discharge one- year mortality, whereas 60 per cent protection was conferred by vaccination before the COVID-19 infection. The history of moderate-to-severe COVID-19 disease [aOR (95% CI): 2.3 (1.4, 3.8)] and any comorbidities [aOR ( 95% CI): 3 (1.9, 4.8)] were associated with post-discharge mortality in the 18-45-yr age bracket as well. Post COVID condition (PCC) was reported in 17.1 per cent of the participants. Death beyond the first follow up was associated with comorbidities [aOR (95%CI): 9.4 (3.4, 26.1)] and reported PCC [aOR (95% CI): 2.7 (1.2, 6)]. Interpretation & conclusions: Prior vaccination protects against post discharge mortality till one year in hospitalized COVID-19 patients. PCC may have long term deleterious effects, including mortality, for which further research is warranted.
引用
收藏
页码:136 / 144
页数:9
相关论文
共 50 条
  • [31] Predictors of severity and mortality among patients hospitalized with COVID-19 in Rhode Island
    Pandita, Aakriti
    Gillani, Fizza S.
    Shi, Yiyun
    Hardesty, Anna
    McCarthy, Meghan
    Aridi, Jad
    Farmakiotis, Dimitrios
    Chiang, Silvia S.
    Beckwith, Curt G.
    PLOS ONE, 2021, 16 (06):
  • [32] IMPACT OF HISPANIC ETHNICITY ON MORTALITY AMONG HOSPITALIZED PATIENTS WITH COVID-19 DIAGNOSIS
    Adrade, Liwayway R.
    Hodgeman, Nicholas
    Mader, Michael J.
    Sanchez-Reilly, Sandra
    Restrepo, Marcos I.
    CHEST, 2022, 162 (04) : 1172A - 1172A
  • [33] Anticoagulants and all-cause mortality among hospitalized COVID-19 patients
    Liang, Caihua
    Zhou, Li
    Doherty, Michael C.
    Gately, Robert V.
    Ogilvie, Rachel P.
    Chomistek, Andrea K.
    Wang, Florence
    Seeger, John D.
    Franklin, Jessica
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 : 78 - 78
  • [34] A machine learning analysis of correlates of mortality among patients hospitalized with COVID-19
    Timothy B. Baker
    Wei-Yin Loh
    Thomas M. Piasecki
    Daniel M. Bolt
    Stevens S. Smith
    Wendy S. Slutske
    Karen L. Conner
    Steven L. Bernstein
    Michael C. Fiore
    Scientific Reports, 13
  • [35] Lupus anticoagulant and mortality in patients hospitalized for COVID-19
    Carmine Gazzaruso
    Giuseppe Mariani
    Carolina Ravetto
    Laura Malinverni
    Elena Tondelli
    Maria Cerrone
    Vittorio Sala
    Luigi Bevilacqua
    Teodoro Altavilla
    Adriana Coppola
    Pietro Gallotti
    Journal of Thrombosis and Thrombolysis, 2021, 52 : 85 - 91
  • [36] Lupus anticoagulant and mortality in patients hospitalized for COVID-19
    Gazzaruso, Carmine
    Mariani, Giuseppe
    Ravetto, Carolina
    Malinverni, Laura
    Tondelli, Elena
    Cerrone, Maria
    Sala, Vittorio
    Bevilacqua, Luigi
    Altavilla, Teodoro
    Coppola, Adriana
    Gallotti, Pietro
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2021, 52 (01) : 85 - 91
  • [37] Mortality in patients hospitalized with COVID-19 in northern Peru
    Leon-Jimenez, Franco
    Vives-Kufoy, Camila
    Failoc-Rojas, Virgilio E.
    Valladares-Garrido, Mario J.
    REVISTA MEDICA DE CHILE, 2021, 149 (10) : 1459 - 1466
  • [38] Post-COVID-19 syndrome among hospitalized COVID-19 patients: a cohort study assessing patients 6 and 12 months after hospital discharge
    Rocha, Roseany Patricia Silva
    de Souza Andrade, Amanda Cristina
    Melanda, Francine Nesello
    Muraro, Ana Paula
    CADERNOS DE SAUDE PUBLICA, 2024, 40 (02):
  • [39] Determinants of post-acute COVID-19 syndrome among hospitalized severe COVID-19 patients: A 2-year follow-up study
    Elias, Tamrat Petros
    Gebreamlak, Tsegaye Wesenseged
    Gebremeskel, Tigist Tesfaye
    Adde, Binyam Lukas
    Abie, Abraham Sisay
    Elias, Bitaniya Petros
    Argaw, Abel Mureja
    Tenaw, Addis Aschenek
    Belay, Biruk Mulugeta
    PLOS ONE, 2024, 19 (05):
  • [40] Mortality Among Hospitalized Nursing Home Residents With COVID-19
    Kohl, Raphael
    Schwinger, Antje
    Juerchott, Kathrin
    Hering, Christian
    Gangnus, Annabell
    Steinhagen-Thiessen, Elisabeth
    Kuhlmey, Adelheid
    Gellert, Paul
    DEUTSCHES ARZTEBLATT INTERNATIONAL, 2022, 119 (16): : 293 - 294